Keyphrases
Head-and-neck Cancer
100%
Hearing Impairment
100%
Radiotherapy
100%
Cisplatin-based Chemotherapy
100%
Pure-tone Average
42%
Predictive Models
28%
Prediction Model
28%
Treatment Initiation
28%
Adverse Effects
14%
Retrospective Cohort Study
14%
Multivariable
14%
Fixed Effects
14%
Cancer Treatment
14%
Cochlea
14%
Academic Medical Centers
14%
Treatment Completion
14%
Clinical Setting
14%
Prediction Accuracy
14%
Mixed Models
14%
Area under the Receiver Operating Characteristic Curve
14%
Hearing Level
14%
Ototoxic
14%
Patient Preference
14%
Cisplatin
14%
Post-radiotherapy
14%
Effect Prediction
14%
Radiotherapy Dose
14%
Informed Patient
14%
Cumulative Cisplatin Dose
14%
Pure Tone Audiometry
14%
Audiometric Data
14%
Medicine and Dentistry
Cisplatin
100%
Head and Neck Cancer
100%
Hearing Impairment
100%
Radiation Therapy
100%
Pure Tone Audiometry
57%
Cancer Therapy
14%
Clinician
14%
Retrospective Cohort Study
14%
Cochlea
14%
Mixed Model
14%
Patient Decision Making
14%
Adverse Effect
14%
Nursing and Health Professions
Hearing Impairment
100%
Head and Neck Cancer
100%
Cisplatin
100%
Radiotherapy
100%
Pure Tone Audiometry
57%
Cohort Analysis
14%
Receiver Operating Characteristic
14%
University Hospital
14%
Cancer Therapy
14%
Patient Decision Making
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Head and Neck Cancer
100%
Cisplatin
100%
Hearing Impairment
100%
Cohort Study
14%
Mixed Model
14%
Neuroscience
Cisplatin
100%
Radiation Therapy
100%
Sensation of Hearing
28%
Adverse Effect
14%
Cochlea
14%
Decision-Making
14%